MX9706825A - El uso farmacologico de ciertos derivados de cistina. - Google Patents

El uso farmacologico de ciertos derivados de cistina.

Info

Publication number
MX9706825A
MX9706825A MX9706825A MX9706825A MX9706825A MX 9706825 A MX9706825 A MX 9706825A MX 9706825 A MX9706825 A MX 9706825A MX 9706825 A MX9706825 A MX 9706825A MX 9706825 A MX9706825 A MX 9706825A
Authority
MX
Mexico
Prior art keywords
pharmacological use
cystine derivatives
certain
derivatives
certain cystine
Prior art date
Application number
MX9706825A
Other languages
English (en)
Other versions
MXPA97006825A (es
Inventor
Hakan Bergstrand
Knut Pettersson
Christer Westerlund
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MX9706825A publication Critical patent/MX9706825A/es
Publication of MXPA97006825A publication Critical patent/MXPA97006825A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un método para el tratamiento de la restenosis usando ciertos derivados de cistina y una preparacion farmacéutica que comprende éstos derivados.
MXPA/A/1997/006825A 1995-03-14 1997-09-08 El uso farmacologico de ciertos derivados de cistina MXPA97006825A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9500897.5 1995-03-14
SE9500897A SE9500897D0 (sv) 1995-03-14 1995-03-14 The pharmacological use of certain cystine derivatives
PCT/SE1996/000320 WO1996028149A1 (en) 1995-03-14 1996-03-12 The pharmacological use of certain cystine derivatives

Publications (2)

Publication Number Publication Date
MX9706825A true MX9706825A (es) 1997-11-29
MXPA97006825A MXPA97006825A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
CZ288219B6 (en) 2001-05-16
CA2214831A1 (en) 1996-09-19
AU701287B2 (en) 1999-01-21
EP0814798A1 (en) 1998-01-07
IL117465A0 (en) 1996-07-23
UA42830C2 (uk) 2001-11-15
NO974143D0 (no) 1997-09-09
WO1996028149A1 (en) 1996-09-19
JPH11501916A (ja) 1999-02-16
AR002716A1 (es) 1998-04-29
AU5018596A (en) 1996-10-02
EE03382B1 (et) 2001-04-16
TW385249B (en) 2000-03-21
PL322328A1 (en) 1998-01-19
SE9500897D0 (sv) 1995-03-14
NO974143L (no) 1997-09-09
HUP9801985A3 (en) 2000-07-28
ZA961749B (en) 1996-09-16
US5883126A (en) 1999-03-16
IS4554A (is) 1997-08-27
CZ280497A3 (cs) 1998-01-14
PL183234B1 (pl) 2002-06-28
EE9700229A (et) 1998-04-15
SK282448B6 (sk) 2002-02-05
CN1183718A (zh) 1998-06-03
NZ303781A (en) 2001-03-30
BR9607225A (pt) 1998-07-07
TR199700945T1 (xx) 1998-02-21
KR19980703055A (ko) 1998-09-05
SK120797A3 (en) 1998-02-04
HUP9801985A2 (hu) 1998-12-28
IL117465A (en) 2000-07-26

Similar Documents

Publication Publication Date Title
AU7578696A (en) Morpholine derivatives and their use as therapeutic agents
HUP9601492A3 (en) Benzimidazol derivatives, process for producing them and pharmaceutical use of them
HUP9801230A3 (en) Benzopyran-derivatives and their use for the production of medicaments for treating estrogen sensitive diseases
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
BG101901A (en) 2-methyl-thieno-benzodiazepine formulation for oral application
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
MX9701342A (es) Formulacion cosolvente de tirilazad para administracion parenteral.
PL323726A1 (en) Novel derivatives of dolastatin, their production and application
AU7678096A (en) Therapeutic medical garments for scars and process
HU9402832D0 (en) Imidazol-4-yl-piperidine derivatives, process for producing them and pharmaceutical use of them
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
EP0751170A3 (en) Compounds derived from a silicone, their preparation and use
WO1993000094A3 (en) Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
HU9503848D0 (en) 3-phenyl-izoquinolin-(2h)-one derivatives, process for producing them and pharmaceutical use of them
PL323177A1 (en) Azacycloalcane derivatives, method of obtaining them and their application for therapeutic purposes
MY129782A (en) Novel medical use
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
GB9508823D0 (en) Drug Derivatives
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
HK1014938A1 (en) Oxazolidinone derivatives, their preparation and therapeutical use
AU3909389A (en) Il-1alpha derivatives and medicament for treating thrombocytopenia
ZA964198B (en) Treatment regime for skin.
AU6406098A (en) Use of minalcipran and its derivatives for preparing a medicine for treating certain psychiatric diseases
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes